Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity
A new series of novelquinoline-2-carboxamides was synthesized. New compounds were evaluated in vitro as dual COXs/LOX inhibitors. Compounds 19 and 27 exhibited the highest potency and selectivity for COX-2 inhibitory activity. Two compounds (19 and 27) have a superior gastric safety profile comparable to indomethacin.